Compare
GHK-Cu vs Thymosin Alpha-1
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
GHK-Cu
120 community reports
Positive 3% · Neutral 97% · Negative 0%
Most reported benefits
Mood
226
Recovery
226
Energy
1
Most reported side effects
Injection site irritation
222
Dose distribution
Median: 2000+ mcg · Most common: 2000+ mcg
0–25
1
25–50
16
50–100
0
100–200
0
200–400
4
400–600
0
600–1000
1
1000–2000
71
2000+
135
Commonly stacked with
How repeat users are trending
Among repeat reporters, 89% said they felt similar to their last entry, 11% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 46 days · Based on 45 repeat reporters
Thymosin Alpha-1
6 community reports
Positive 100% · Neutral 0% · Negative 0%
Most reported benefits
Recovery
6
Dose distribution
Median: 400–600 mcg · Most common: 400–600 mcg
0–25
0
25–50
0
50–100
0
100–200
0
200–400
0
400–600
4
600–1000
0
1000–2000
2
2000+
0